Michelle A. Kelliher

16.9k total citations · 3 hit papers
95 papers, 10.9k citations indexed

About

Michelle A. Kelliher is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Michelle A. Kelliher has authored 95 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 48 papers in Immunology and 25 papers in Cancer Research. Recurrent topics in Michelle A. Kelliher's work include Immune Response and Inflammation (28 papers), NF-κB Signaling Pathways (24 papers) and Acute Lymphoblastic Leukemia research (22 papers). Michelle A. Kelliher is often cited by papers focused on Immune Response and Inflammation (28 papers), NF-κB Signaling Pathways (24 papers) and Acute Lymphoblastic Leukemia research (22 papers). Michelle A. Kelliher collaborates with scholars based in United States, Germany and Canada. Michelle A. Kelliher's co-authors include Philip Leder, Stefan Grimm, Yasumasa Ishida, Ben Z. Stanger, Frank C. Kuo, Katherine A. Fitzgerald, Thomas H. Lee, Nicole Hermance, Manolis Pasparakis and Naomi Rosenberg and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Michelle A. Kelliher

92 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal

1998 905 citations Michelle A. Kelliher et al. profile →
Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death

2018 800 citations Pontus Ørning, Dan Weng et al. Science profile →
RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation

2004 674 citations Michelle A. Kelliher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle A. Kelliher United States	52	6.8k	5.1k	2.3k	1.6k	1.4k	95	10.9k
Michael Hahne France	41	5.9k 0.9×	5.5k 1.1×	1.7k 0.8×	2.1k 1.3×	483 0.3×	96	10.6k
Gwyn T. Williams United Kingdom	41	6.0k 0.9×	3.0k 0.6×	2.7k 1.2×	1.8k 1.1×	390 0.3×	121	10.1k
Benjamin T. Kile Australia	50	4.6k 0.7×	2.8k 0.6×	671 0.3×	1.5k 0.9×	1.9k 1.4×	137	8.3k
Frank Köntgen Australia	25	3.7k 0.5×	5.0k 1.0×	1.1k 0.5×	1.4k 0.9×	563 0.4×	28	9.2k
David Allman United States	57	3.3k 0.5×	6.7k 1.3×	769 0.3×	2.4k 1.5×	1.1k 0.8×	112	11.0k
Nathalie Droin France	39	4.2k 0.6×	2.7k 0.5×	1.2k 0.5×	1.9k 1.2×	888 0.6×	109	7.8k
Raymond G. Goodwin United States	37	8.0k 1.2×	8.2k 1.6×	2.9k 1.3×	3.1k 1.9×	695 0.5×	52	14.8k
Yuka Kanno United States	59	4.3k 0.6×	11.4k 2.3×	1.2k 0.5×	3.9k 2.5×	1.2k 0.8×	97	17.3k
Ann Marshak‐Rothstein United States	59	4.8k 0.7×	12.0k 2.4×	1.1k 0.5×	1.4k 0.9×	511 0.4×	180	15.7k
Tomohiko Tamura Japan	54	3.9k 0.6×	5.9k 1.2×	1.0k 0.5×	2.2k 1.4×	586 0.4×	139	10.3k

Countries citing papers authored by Michelle A. Kelliher

Since Specialization

Citations

This map shows the geographic impact of Michelle A. Kelliher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Kelliher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Kelliher more than expected).

Fields of papers citing papers by Michelle A. Kelliher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle A. Kelliher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Kelliher. The network helps show where Michelle A. Kelliher may publish in the future.

Co-authorship network of co-authors of Michelle A. Kelliher

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle A. Kelliher. A scholar is included among the top collaborators of Michelle A. Kelliher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle A. Kelliher. Michelle A. Kelliher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Banday, Shahid, Alok Mishra, Amjad Ali, et al.. (2025). The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma. Nature Communications. 16(1). 1267–1267.

Ørning, Pontus, Roland Elling, Michelle A. Kelliher, et al.. (2025). Raver1 links Ripk1 RNA splicing to caspase-8-mediated pyroptotic cell death, inflammation, and pathogen resistance. Proceedings of the National Academy of Sciences. 122(7). e2420802122–e2420802122. 2 indexed citations

O’Connor, Kevin W., Justine E. Roderick, Keshab Kumar Karna, et al.. (2024). The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance. Leukemia. 38(5). 951–962. 4 indexed citations

Karna, Keshab Kumar, Joanne A. O’Donnell, Lucio H. Castilla, et al.. (2024). ZBP1 activation triggers hematopoietic stem and progenitor cell death resulting in bone marrow failure in mice. Proceedings of the National Academy of Sciences. 121(4). e2309628121–e2309628121. 3 indexed citations

Roderick, Justine E., Kevin W. O’Connor, Katherine Tang, et al.. (2020). Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death. Blood. 137(4). 500–512. 9 indexed citations

Ørning, Pontus, Dan Weng, Kristian K. Starheim, et al.. (2018). Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death. Science. 362(6418). 1064–1069. 800 indexed citations breakdown →

Dastur, Anahita, Carlotta Costa, August Williams, et al.. (2018). NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263. Clinical Cancer Research. 25(1). 312–324. 16 indexed citations

Garcia‐Carbonell, Ricard, Jerry Wong, Ju Youn Kim, et al.. (2018). Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death. Proceedings of the National Academy of Sciences. 115(39). E9192–E9200. 75 indexed citations

Illendula, Anuradha, John Anto Pulikkan, Justine E. Roderick, et al.. (2017). RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia. Blood. 130(15). 1722–1733. 65 indexed citations

10.

O’Donnell, Joanne A., Justine E. Roderick, Dalia Martinez‐Marin, et al.. (2017). Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity. The Journal of Immunology. 200(2). 737–748. 29 indexed citations

11.

Chonghaile, Tríona Ní, Justine E. Roderick, Jeremy Ryan, et al.. (2014). Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199. Cancer Discovery. 4(9). 1074–1087. 190 indexed citations

12.

Roderick, Justine E., Nicole Hermance, Matija Zelic, et al.. (2014). Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis. Proceedings of the National Academy of Sciences. 111(40). 14436–14441. 71 indexed citations

13.

Polykratis, Apostolos, Nicole Hermance, Matija Zelic, et al.. (2014). Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In Vivo. The Journal of Immunology. 193(4). 1539–1543. 259 indexed citations

14.

Mansour, Marc R., Takaomi Sanda, Lee N. Lawton, et al.. (2013). The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. The Journal of Experimental Medicine. 210(8). 1545–1557. 104 indexed citations

15.

Sanda, Takaomi, Lee N. Lawton, M. Inmaculada Barrasa, et al.. (2012). Core Transcriptional Regulatory Circuit Controlled by the TAL1 Complex in Human T Cell Acute Lymphoblastic Leukemia. Cancer Cell. 22(2). 209–221. 216 indexed citations

16.

Yang, Yibin, Fang Xia, Nicole Hermance, et al.. (2011). A Cytosolic ATM/NEMO/RIP1 Complex Recruits TAK1 To Mediate the NF-κB and p38 Mitogen-Activated Protein Kinase (MAPK)/MAPK-Activated Protein 2 Responses to DNA Damage. Molecular and Cellular Biology. 31(14). 2774–2786. 118 indexed citations

17.

Draheim, Kyle, et al.. (2010). A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice. Oncogene. 30(10). 1252–1260. 29 indexed citations

18.

Cullion, Kathleen, Kyle Draheim, Nicole Hermance, et al.. (2009). Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood. 113(24). 6172–6181. 105 indexed citations

19.

O’Neil, Jennifer, Jennifer A. Calvo, Keith McKenna, et al.. (2005). Activating Notch1 mutations in mouse models of T-ALL. Blood. 107(2). 781–785. 177 indexed citations

20.

O’Neil, Jennifer, et al.. (2001). The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice. Oncogene. 20(29). 3897–3905. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact